1/197
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Levothyroxine
Brand: Synthroid, Levoxyl, Levothroid
Class: synthetic thyroid hormone
Indication: hypothyroidism, myxedema coma
MOA: synthetic T4 hormone which is converted to T3 hormone to exert metabolic effects by supplementing endogenous T3
ADR: tachycardia/palpitations, insomnia, weight loss, diarrhea
Not renally or hepatically dosed
Dessicated thyroid
Brand: Armour Thyroid
Class: thyroid hormone
Indication: hypothyroidim, myxedema coma
MOA: naturally derived T3 and T4 hormones that exert metabolic effects by supplementing endogenous T3
ADR: tachycardia/palpitations, insomnia, weight loss, diarrhea
Not renally or hepatically dosed
Bimatoprost
Brand: Lumigan
Class: prostaglandin analog
Indication: open-angle glaucoma, ocular hypertension
MOA: mimics natural prostaglandin to increase the outflow of aqueous humor
ADR: conjunctival hyperemia, foreign body sensation, eye pruritus
Not renally or hepatically dosed
Latanoprost
Brand: Xalatan
Class: prostaglandin analog
Indication: open-angle glaucoma, ocular hypertension
MOA: mimics natural prostaglandin to increase the outflow of aqueous humor
ADR: conjunctival hyperemia, foreign body sensation, eye pruritus
Not renally or hepatically dosed
Timolol
Brand: Lumigan
Class: beta-blocker (nonselective)
Indication: open-angle glaucoma, ocular hypertension
MOA: blocks beta-1 and beta-2 receptors to reduce intraocular pressure by decreasing aqueous humor production and increasing outflow of aqueous humor
ADR: eye irritation, headache, signs of systemic absorption
Not renally or hepatically dosed
Brimonidine
Brand: Alphagan P
Class: alpha adrenergic agonist
Indication: open-angle glaucoma, ocular hypertension
MOA: alpha-2 agonist that reduces aqueous humor formation and increases uveoscleral outflow
ADR: allergic conjunctivitis, conjunctival hyperemia, itching, drowsiness in children
Not renally or hepatically dosed
Triamcinolone (topical or nasal)
Brand: Kenalog (topical) Nasacort (nasal)
Class: corticosteroid
Indication: dermatitis (topical), allergic rhinitis (nasal)
MOA: decreases chemical mediators of inflammation by inducing phospholipase A2 (PLA2) inhibitory proteins and inhibiting arachidonic acid release resulting in anti-inflammatory, antipruritic, and vasoconstrictive effects
ADR: local burning, itching, skin atrophy, secondary infection
Not renally or hepatically dosed
Hydrocortisone
Brand: Anusol-HC, Proctosol-HC
Class: corticosteroid
Indication: pruritis, dermatitis, hemorrhoids, UC
MOA: decreases chemical mediators of inflammation by inducing phospholipase A2 (PLA2) inhibitory proteins and inhibiting arachidonic acid release resulting in anti-inflammatory, antipruritic, and vasoconstrictive effects
ADR: local burning, itching, skin atrophy, secondary infection
Not renally or hepatically dosed
Clobetasol (topical)
Brand: Temovate, Impoyz
Class: corticosteroid
Indication: psoriasis, dermatoses
MOA: decreases chemical mediators of inflammation by inducing phospholipase A2 (PLA2) inhibitory proteins and inhibiting arachidonic acid release resulting in anti-inflammatory, antipruritic, and vasoconstrictive effects
ADR: local burning, itching, skin atrophy, secondary infection
Not renally or hepatically dosed
Empagliflozin
Brand: Jardiance
Class: SGLT2 inhibitor
Indication: T2DM, CKD, HF
MOA: inhibits sodium-glucose cotransporter 2 (SGLT2) in the proximal renal tubules which reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, which increases urinary glucose excretion
ADR: genital mycotic infections, UTIs, increased urination, rare hypotension
Renally dosed
Metformin
Brand: Glucophage, Glumetza, Riomet, Fortamet
Class: biguanide
Indication: T2DM
MOA: decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity
ADR: GI (N/V/D, flatulence, bloating), decreased vitamin B12 absorption, rare lactic acidosis
Renally and hepatically dosed
Glipizide
Brand: Glucotrol, Glucotrol XL
Class: sulfonylurea
Indication: T2DM
MOA: stimulates insulin release from the pancreas, reduces glucose output from the liver, and increases peripheral insulin sensitivy which decreases glucose levels
ADR: hypoglycemia
Renally and hepatically dosed
Glimepiride
Brand: Amaryl
Class: sulfonylurea
Indication: T2DM
MOA: stimulates insulin release from the pancreas, reduces glucose output from the liver, and increases peripheral insulin sensitivy which decreases glucose levels
ADR: hypoglycemia
Renally dosed
Pioglitazone
Brand: Actos
Class: thiazolidinediones
Indication: T2DM
MOA: binds to peroxisome proliferator-activated receptor-gamma (PPAR) which regulates insulin responsive genes, ultimately decreasing insulin resistance by improving target cell response to insulin
ADR: hypoglycemia, edema, increased bladder cancer risk (dose/time dependent)
Hepatically dosed
Insulin glargine
Brand: Basaglar, Lantus, Toujeo
Class: long acting insulin
Indication: T1DM, T2DM
MOA: promotes cellular uptake of glucose, fatty acids, and amino acids, and their conversion to glycogen, triglycerides, and proteins; ultimately regulates glucose levels
ADR: hypoglycemia, injection site pain/reaction, weight gain
Not renally or hepatically dosed
Insulin aspart
Brand: Novolog
Class: rapid acting insulin
Indication: T1DM, T2DM
MOA: promotes cellular uptake of glucose, fatty acids, and amino acids, and their conversion to glycogen, triglycerides, and proteins; ultimately regulates glucose levels
ADR: hypoglycemia, injection site pain/reaction, weight gain
Not renally or hepatically dosedADR:
Insulin lispro
Brand: Humalog
Class: rapid acting insulin
Indication: T1DM, T2DM
MOA: promotes cellular uptake of glucose, fatty acids, and amino acids, and their conversion to glycogen, triglycerides, and proteins; ultimately regulates glucose levels
ADR: hypoglycemia, injection site pain/reaction, weight gain
Not renally or hepatically dosed
Insulin degludec
Brand: Tresiba
Class: long acting insulin
Indication: T1DM, T2DM
MOA: promotes cellular uptake of glucose, fatty acids, and amino acids, and their conversion to glycogen, triglycerides, and proteins; ultimately regulates glucose levels
ADR: hypoglycemia, injection site pain/reaction, weight gain
Not renally or hepatically dosed
Hydrochlorothiazide
Brand: Microzide
Class: thiazide diuretic
Indication: edema, hypertension
MOA: inhibits sodium reabsorption in the distal tubule causing increased excretion of sodium and hydrogen ions
ADR: hypotension, electrolyte disturbances (hypokalemia, hypomagnesemia, hyponatremia, hypercalcemia, hyperuricemia/gout)
Renally dosed
Chlorthalidone
Brand: Hygroton
Class: thiazide diuretic
Indication: edema, hypertension
MOA: inhibits sodium reabsorption in the distal tubule causing increased excretion of sodium and hydrogen ions
ADR: hypotension, electrolyte disturbances (hypokalemia, hypomagnesemia, hyponatremia, hypercalcemia, hyperuricemia/gout)
Renally dosed
Triamterene/hydrochlorothiazide
Brand: Dyazide, Maxzide
Class: potassium sparing diuretic/thiazide diuretic
Indication: edema, hypertension
MOA: blocks epithelial sodium channels which inhibits sodium reabsoption, decreases the function of Na+/K+ ATPase, causing potassium retention and decreased Ca, Mg, and H excretion/ inhibits sodium reabsorption in the distal tubule causing increased excretion of sodium and hydrogen ions
ADR: hypotension, electrolyte disturbances (hyperkalemia or hypokalemia, hypomagnesemia, hyponatremia, hypercalcemia), hyperuricemia/gout
Renally dosed
Furosemide
Brand: Lasix
Class: loop diuretic
Indication: edema, hypertension, acute pulmonary edema
MOA: inhibits sodium and chloride reabsorption in the loop of Henle and interferes with chloride-binding cotransport system
ADR: fluid/electrolyte loss, increased urination, nephrotoxicity, ototoxicity
Renally dosed
Spironolactone
Brand: Aldactone
Class: potassium-sparing diuretic, aldosterone receptor antagonist, mineralcorticoid receptor antagonist
Indication: edema, hypertension, primary hyperaldosteronism
MOA: competes with aldosterone in distal convoluted renal tubule which increases sodium chloride and water excretion while conserving potassium and hydrogen ions
ADR: hyperkalemia, gynecomastia, menstrual irregularities
Renally dosed
Amlodipine
Brand: Norvasc
Class: DHP calcium channel blocker
Indication: angina, hypertension
MOA: calcium channel blocker that inhibits the influx of calcium across cell membranes in vascular smooth muscle causing vasodilation
ADR: peripheral edema, flushing, HA
Hepatically dosed
Nifedipine
Brand: Procardia, Nifedical XL, Adalat CC
Class: DHP calcium channel blocker
Indication: angina, hypertension
MOA: calcium channel blocker that inhibits the influx of calcium across cell membranes in vascular smooth muscle causing vasodilation
ADR: peripheral edema, flushing, HA
Not renally or hepatically dosed
Diltiazem
Brand: Cardizem (CD), Cartia, Dilacor, Dilt-XR, Tiazac
Class: non-DHP calcium channel blocker
Indication: angina, hypertension,arrhythmia (rate control)
MOA: calcium channel blocker that inhibits the influx of calcium across cell membranes in vascular smooth muscle causing slowing of the SA and AV node conduction
ADR: peripheral edema, bradycardia
Not renally or hepatically dosed
Verapamil
Brand: Isoptin, Calan, Verelan
Class: non-DHP calcium channel blocker
Indication: angina, hypertension,arrhythmia (rate control)
MOA: calcium channel blocker that inhibits the influx of calcium across cell membranes in vascular smooth muscle causing slowing of the SA and AV node conduction
ADR: peripheral edema, bradycardia
Hepatically dosed
Amlodipine/benazepril
Brand: Lotrel
Class: DHP calcium channel blocker/ACE-inhibitor
Indication: hypertension
MOA: calcium channel blocker that inhibits the influx of calcium across cell membranes in vascular smooth muscle causing vasodilation/inhibits angiotensin-converting enzyme thus preventing conversion of angiotenin I to angiotensin II, ultimately reducing aldosterone secretion and increasing plasma renin activity
ADR: peripheral edema, flushing, HA/cough, angioedema
Both renally and hepatically dosed
Atorvastatin
Brand: Lipitor
Class: HMG-CoA reductase inhibitor
Indication: dyslipidemia, primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD)
MOA: competitive inhibitor of HMG-CoA reductase, the rate limiting enzyme in cholesterol synthesis which causes a reduction in total cholesterol, LDL, triglycerides, and increases HDL
ADR: constipation, dyspepsia, myalgia
Renally dosed
Simvastatin
Brand: Zocor
Class: HMG-CoA reductase inhibitor
Indication: dyslipidemia, primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD)
MOA: competitive inhibitor of HMG-CoA reductase, the rate limiting enzyme in cholesterol synthesis which causes a reduction in total cholesterol, LDL, triglycerides, and increases HDL
ADR: constipation, dyspepsia, myalgia
Renally dosed
Rosuvastatin
Brand: Crestor
Class: HMG-CoA reductase inhibitor
Indication: dyslipidemia, primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD)
MOA: competitive inhibitor of HMG-CoA reductase, the rate limiting enzyme in cholesterol synthesis which causes a reduction in total cholesterol, LDL, triglycerides, and increases HDL
ADR: constipation, dyspepsia, myalgia
Renally and hepatically dosed
Pravastatin
Brand: Pravachol
Class: HMG-CoA reductase inhibitor
Indication: dyslipidemia, primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD)
MOA: competitive inhibitor of HMG-CoA reductase, the rate limiting enzyme in cholesterol synthesis which causes a reduction in total cholesterol, LDL, triglycerides, and increases HDL
ADR: constipation, dyspepsia, myalgia
Renally and hepatically dosed
Lovastatin
Brand: Mevacor, Altoprev
Class: HMG-CoA reductase inhibitor
Indication: dyslipidemia, primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD)
MOA: competitive inhibitor of HMG-CoA reductase, the rate limiting enzyme in cholesterol synthesis which causes a reduction in total cholesterol, LDL, triglycerides, and increases HDL
ADR: constipation, dyspepsia, myalgia
Renally and hepatically dosed
Ezetimibe
Brand: Zetia
Class: A2-Azetidinone
Indication: dyslipidemia, primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD)
MOA: inhibits cholesterol absorption in the small intestine which decreases LDL, total cholesterol, and triglycerides and increases HDL
ADR: myalgia, elevated liver transaminases, arthraliga
Hepatically dosed
Omega 3 ethyl esters
Brand: Lovaza
Class: omega 3 fatty acid
Indication: dyslipidemia, primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD)
MOA: not completely understood, causes reduction in hepatic production of triglyceride-rich VLDL, mainly lowering triglycerides
ADR: belching, dyspepsia, bad taste
Not renally or hepatically dosed
Fenofibrate
Brand: Tricor
Class: fibric acid
Indication: hypertriglyceridemia
MOA: activates peroxisome proliferator activated receptor-a (PPARa) which increases lipolysis and elimination of triglyceride rich particles, lowering total cholesterol, LDL, and triglycerides
ADR: myalgia, rash, elevated liver transaminases
Renally and hepatically dosed
Semaglutide
Brand: Ozempic, Rybelsus (PO), w Wegovy
Class: GLP-1 receptor agonist
Indication: T2DM, CKD, weight management (Wegovy)
MOA: agonizes glucagon-like peptide-1 (GLP-1) receptor, which increases glucose-dependent insulin secretion, decreases inappropriate glucagon secretion, slows gastric emptying, and increases satiety
ADR: GI, rare pancreatitis, renal impairment, medually thyroid carcinoma
Not renally or hepatically dosed
Liraglutide
Brand: Victoza, Saxenda
Class: GLP-1 receptor agonist
Indication: T2DM, weight management (Saxenda)
MOA: agonizes glucagon-like peptide-1 (GLP-1) receptor, which increases glucose-dependent insulin secretion, decreases inappropriate glucagon secretion, slows gastric emptying, and increases satiety
ADR: GI, rare pancreatitis, renal impairment, medually thyroid carcinoma
Not renally or hepatically dosed
Dulaglutide
Brand: Trulicity
Class: GLP-1 receptor agonist
Indication: T2DM
MOA: agonizes glucagon-like peptide-1 (GLP-1) receptor, which increases glucose-dependent insulin secretion, decreases inappropriate glucagon secretion, slows gastric emptying, and increases satiety
ADR: GI, rare pancreatitis, renal impairment, medually thyroid carcinoma
Not renally or hepatically dosed
Tirzepatide
Brand: Mounjaro, Zepbound
Class: GIP/GLP-1 receptor agonist
Indication: T2DM, obstructive sleep apnea, weight management (Zepbound)
MOA: agonizes glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors,which increases glucose-dependent insulin secretion, decreases inappropriate glucagon secretion, slows gastric emptying, and increases satiety
ADR: GI, rare pancreatitis, renal impairment, medually thyroid carcinoma
Not renally or hepatically dosed
Benazepril
Brand: Lotensin
Class: ACE-I
Indication: HTN, HF, proteinuria
MOA: inhibits angiotensin-converting enzyme thus preventing conversion of angiotenin I to angiotensin II, ultimately reducing aldosterone secretion and increasing plasma renin activity
ADR: cough, angioedema, HA
Renally dosed
Lisinopril
Brand: Prinivil, Zestril
Class: ACE-I
Indication: HTN, HF, proteinuria
MOA: inhibits angiotensin-converting enzyme thus preventing conversion of angiotenin I to angiotensin II, ultimately reducing aldosterone secretion and increasing plasma renin activity
ADR: cough, angioedema, HA
Renally dosed
Lisinopril/hydrochlorothiazide
Brand: Zestoretic, Prinzide
Class: ACE-I/thiazide diuretic
Indication: HTN, HF, proteinuria
MOA: inhibits angiotensin-converting enzyme thus preventing conversion of angiotenin I to angiotensin II, ultimately reducing aldosterone secretion and increasing plasma renin activity/inhibits sodium reabsorption in the distal tubule causing increased excretion of sodium and hydrogen ions
ADR: cough, angioedema, HA, hypotension, electrolyte disturbances (hypokalemia, hypomagnesemia, hyponatremia, hypercalcemia), hyperuricemia/gout
Renally dosed
Ramipril
Brand: Altace
Class: ACE-I
Indication: HTN, HF, proteinuria
MOA: inhibits angiotensin-converting enzyme thus preventing conversion of angiotenin I to angiotensin II, ultimately reducing aldosterone secretion and increasing plasma renin activity
ADR: cough, angioedema, HA
Renally dosed
Olmesartan
Brand: Benicar
Class: ARB
Indication: HTN, HF, proteinuria
MOA: competitive antagonism of angiotensin II receptor blocks vasoconstriction, aldosterone secretion, sympathetic outflow, and renal sodium reabsorption
ADR: dizziness, increased BUN, hyperkalemia
Not renally or hepatically dosed
Losartan
Brand: Cozaar
Class: ARB
Indication: HTN, HF, proteinuria
MOA: competitive antagonism of angiotensin II receptor blocks vasoconstriction, aldosterone secretion, sympathetic outflow, and renal sodium reabsorption
ADR: dizziness, increased BUN, hyperkalemia
Not renally or hepatically dosed
Valsartan
Brand: Diovan
Class: ARB
Indication: HTN, HF, proteinuria
MOA: competitive antagonism of angiotensin II receptor blocks vasoconstriction, aldosterone secretion, sympathetic outflow, and renal sodium reabsorption
ADR: dizziness, increased BUN, hyperkalemia
Not renally or hepatically dosed
Irbesartan
Brand: Avapro
Class: ARB
Indication: HTN, HF, proteinuria
MOA: competitive antagonism of angiotensin II receptor blocks vasoconstriction, aldosterone secretion, sympathetic outflow, and renal sodium reabsorption
ADR: dizziness, increased BUN, hyperkalemia
Not renally or hepatically dosed
Valsartan/hydrochlorothiazide
Brand: Diovan-HCT
Class: ARB/thiazide diuretic
Indication: HTN, HF, proteinuria
MOA: competitive antagonism of angiotensin II receptor blocks vasoconstriction, aldosterone secretion, sympathetic outflow, and renal sodium reabsorption/inhibits sodium reabsorption in the distal tubule causing increased excretion of sodium and hydrogen ions
ADR: dizziness, increased BUN, hyperkalemia/hypotension, electrolyte disturbances (hypokalemia, hypomagnesemia, hyponatremia, hypercalcemia), hyperuricemia/gout
Renally dosed
Losartan/hydrochlorothiazide
Brand: Hyzaar
Class: ARB/thiazide diuretic
Indication: HTN, HF, proteinuria
MOA: competitive antagonism of angiotensin II receptor blocks vasoconstriction, aldosterone secretion, sympathetic outflow, and renal sodium reabsorption/inhibits sodium reabsorption in the distal tubule causing increased excretion of sodium and hydrogen ions
ADR: dizziness, increased BUN, hyperkalemia/hypotension, electrolyte disturbances (hypokalemia, hypomagnesemia, hyponatremia, hypercalcemia), hyperuricemia/gout
Renally dosed
Nitrofurantoin
Brand: Macrobid
Class: antibiotic
Indication: UTI
MOA: inhibits acetyl-coenzyme A which interferes with carbohydrate metabolism in bacteria
ADR: N/V
Metronidazole
Brand: Flagyl
Class: nitroimidazole
Indication: bacterial vaginosis, trichomoniasis, anaerobic infections
MOA: reduced to unstable compounds which bind to DNA and cause strand breakage and cell death
ADR: N/D, HA, vaginitis, rare disulfiram like reactions (with alcohol ingestion)
Hepatically dosed
Benzonatate
Brand: Tessalon
Class: antitussive
Indication: cough suppressant
MOA: reduces the cough reflex by anesthetizing the stretch receptors in respiratory passages
ADR: rare hypersensitivty reactions, visual hallucinations
Not renally or hepatically dosed
Fluconazole
Brand: Diflucan
Class: azole antifungal
Indication: candida (fungus) infection, cryptococcus (fungus) meningitis
MOA: interferes with fungal CYP450 activity which decreases ergosterol synthesis and inhibits cell membrane formation
ADR: N/V, HA, rare skin rash, hepatotoxicity, QT prolongation
Renally dosed
Ketoconazole
Brand: Nizoral (topical)
Class: imidazole antifungal agent
Indication: Oral: Fungal infections (due to Candida, blastomycosis, coccidiomycosis, histoplasmosis, etc.)
Cream/topical: tinea infections (superficial fungal infections of the skin, nails), seborrheic dermatitis
Shampoo: dandruff
MOA: interferes with fungal CYP450 activity which decreases ergosterol synthesis and inhibits cell membrane formation
ADR: N/V, HA, rare skin rash, hepatotoxicity, QT prolongation
Hepatically dosed
Oseltamivir
Brand: Tamiflu
Class: neuraminidase inhibitor (antiviral agent)
Indication: influenza
MOA: a prodrug; its active form inhibits influenza virus neuraminidase, which is an enzyme that cleaves the budding viral progeny from its attachment point
ADR: N/V, rare anaphylaxid or serious skin reactions
Renally dosed
Valacyclovir
Brand: Valtrex
Class: antiviral agent
Indication: genital herpes, shingles, cold sores, chickenpox
MOA: prodrug of acyclovir; inhibits DNA synthesis and viral replication by competing with deoxyguanosine triphosphate and incorporating into viral DNA to terminate the chain
ADR: N/V, HA, rash
Renally dosed
Acyclovir
Brand: Zovirax
Class: antiviral agent
Indication: genital herpes, shingles, cold sores, chicken pox
MOA: inhibits DNA synthesis and viral replication by competing with deoxyguanosine triphosphate and incorporating into viral DNA to terminate the chain
ADR: N/V, HA, rash
Renally dosed
Amoxicillin
Brand: Amoxil, Trimox
Class: penicillin antibiotic
Indication: pharyngitis/tonsilitis, otitis media, LRTIs, skin and skin structure infections, UTI
MOA: inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins which inhibits the final step of peptidoglycan synthesis in cell walls
ADR: diarrhea, nausea, rash
Renally dosed
Piperacillin/tazobactam
Brand: Zosyn
Class: penicillin antibiotic
Indication: intra-abdominal infections, LRTIs, serious or severe skin and skin structure infections
MOA: inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins which inhibits the final step of peptidoglycan synthesis in cell walls/inhibits beta-lactamases that inactivate piperacillin
ADR: diarrhea, nausea, rare C diff infection, hematologic toxicity
Renally dosed
Amoxicillin/clavulanate
Brand: Augmentin
Class: penicillin antibiotic
Indication: otitis media, URTIs, LRTIs, skin and skin structure infections, UTI
MOA: inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins which inhibits the final step of peptidoglycan synthesis in cell walls/inhibits beta-lactamases that inactivate amoxicillin
ADR: diarrhea, nausea, rash
Renally dosed
Azithromycin
Brand: Zithromax, Zmax
Class: macrolide antibiotic
Indication: URTIs, STIs, otitis media, pharyngitis/tonsilitis, pelvic inflammatory disease
MOA: binds to 50s ribosomal subunit of bacteria which suppresses RNA-dependent protein synthesis
ADR: N/V/D, dermatologic reactions, QT prolongation
Not renally or hepatically dosed
Doxycycline
Brand: Vibramycin
Class: tetracycline antibiotic
Indication: STIs, acne, skin and soft tissue infections, LRTIs, lyme disease, rocky mountain spotted fever
MOA: binds to 30s ribosomal subunit which prevents bacterial protein synthesis
ADR: diarrhea, photosensitivity, discoloration of forming teeth, rare esophageal injry, c diff infection
Not renally or hepatically dosed
Cefdinir
Brand: Omnicef
Class: cephalosporin antibiotic (3rd gen)
Indication: URTId, LRTId, pharyngitis/tonsilitis, skin and skin structure infections, otitis media
MOA: inhibits cell wall synthesis by binding to penicillin-binding proteins to inhibit the final step of peptidoglycan synthesis
ADR: diarrhea, rare c diff infection, hypersensitivity
Renally dosed
Ceftriaxone
Brand: Rocephin
Class: cephalosporin antibiotic (3rd gen)
Indication: bloodstream infection, bone and joint infections, intra-abdominal infection, LRTIs, acute otitis media, skin and soft tissue infections, STIs
MOA: inhibits cell wall synthesis by binding to penicillin-binding proteins to inhibit the final step of peptidoglycan synthesis
ADR: diarrhea, rare c diff infection, hypersensitivity
Not renally or hepatically dosed
Cephalexin
Brand: Keflex
Class: cephalosporin antibiotic (1st gen)
Indication: pharyngitis, skin and skin structure infections, UTI
MOA: inhibits cell wall synthesis by binding to penicillin-binding proteins to inhibit the final step of peptidoglycan synthesis
ADR: diarrhea, rare c diff infection, hypersensitivity
Renally adjusted
Sulfamethoxazole/trimethoprim
Brand: Bactrim, Septra
Class: sulfonamide antibiotic
Indication: LRTIs, UTI, skin and soft tissue infections
MOA: interferes with bacterial folic acid synthesis by inhibiting para-aminobenzoic acid (PABA)/blocks the production of tetrahydrofolic acid by inhibiting dihydrofolate reductase
ADR: nausea, diarrhea, rare Stevens-Johnson-Syndrome, hyperkalemia, hypoglycemia, hemolytic anemia (in G6PD deficiency)
Renally adjusted
Ciprofloxacin
Brand: Cipro
Class: fluoroquinolone antibiotic
Indication: infectious diarrhea, UTI, skin and skin structure infections, bone and joint infections, intra-abdominal infections
MOA: interferes with DNA gyrase to inhibit bacterial DNA synthesis
ADR: N/V/D, rare arthralgia, myalgia, tendonopathy, QT prolongation, renal/hepatic/dermatologic/hematologic toxicity
Renally dosed
Clindamycin
Brand: Cleocin
Class: lincosamide antibiotic
Indication: skin ans soft tissue infections, intrabdominal infections
MOA: binds to 50s ribosomal subunit to prevent peptide bond formation and inhibit bacterial protein synthesis
ADR: N/V/D, rash, rare c diff infection
Not renally or hepatically dosed
Vancomycin
Brand: Firvanq, Vancocin HCI, Vancosol Pack
Class: glycopeptide antibiotic
Indication: C diff infection, endocarditis, enterocolitis, serious or severe blood stream infections, bone infections, LRTIs, and skin and skin structure infections
MOA: inhibits bacterial cell wall synthesis by blocking glycopeptide polymerization by binding to D-alanyl-D-alanine
ADR: N/V/D, nephrotoxicity, ototoxicity
Renally adjusted
Albuterol
Brand: Proventil, Ventolin, Proair
Class: beta-2 agonist
Indication: asthma (acute exacerbation therapy), exercise induced asthma (preventative therapy)
MOA: stimulates adenyl cyclase which causes the formation of cAMP which causes relaxation of bronchial smooth muscle
ADR: pharyngitis, tachycardia, nervousness, tremor
Not renally or hepatically dosed
Fluticasone (inhalation)
Brand: Flovent
Class: corticosteroid
Indication: asthma (maintenance therapy)
MOA: decreases chemical mediators of inflammation by inducing phospholipase A2 (PLA2) inhibitory proteins and inhibiting arachidonic acid release resulting in anti-inflammatory effects
ADR: pharyngeal candidiasis
Not renally or hepatically dosed
Fluticasone (nasal)
Brand: Flonase
Class: corticosteroid
Indication: rhinitis
MOA: decreases chemical mediators of inflammation by inducing phospholipase A2 (PLA2) inhibitory proteins and inhibiting arachidonic acid release resulting in anti-inflammatory effects
ADR: nasal burning, epistaxis, pharyngitis
Not renally or hepatically dosed
Budesonide/formoterol
Brand: Symbicort
Class: corticosteroid/beta-2 agonist
Indication: asthma and COPD maintenance therapy
MOA: decreases chemical mediators of inflammation by inducing phospholipase A2 (PLA2) inhibitory proteins and inhibiting arachidonic acid release resulting in anti-inflammatory effects/selectively agonizes B2 receptots causing bronchial smooth muscle relaxation
ADR: URTIs, pharyngeal candidiasis
Not renally or hepatically dosed
Fluticasone/vilanterol
Brand: Breo Ellipta
Class: corticosteroid/beta-2 agonist
Indication: asthma and COPD maintenance therapy
MOA: decreases chemical mediators of inflammation by inducing phospholipase A2 (PLA2) inhibitory proteins and inhibiting arachidonic acid release resulting in anti-inflammatory effects/selectively agonizes B2 receptots causing bronchial smooth muscle relaxation
ADR: URTIs, pharyngeal candidiasis
Not renally or hepatically dosed
Fluticasone/salmeterol
Brand: Advair
Class: corticosteroid/beta-2 agonist
Indication: asthma and COPD maintenance therapy
MOA: decreases chemical mediators of inflammation by inducing phospholipase A2 (PLA2) inhibitory proteins and inhibiting arachidonic acid release resulting in anti-inflammatory effects/selectively agonizes B2 receptots causing bronchial smooth muscle relaxation
ADR: URTIs, pharyngeal candidiasis
Not renally or hepatically dosed
Albuterol/ipratropium
Brand: Combivent Respimat
Class: beta-2 agonist/anticholinergic agent
Indication: asthma and COPD acute exacerbation therapy
MOA: stimulates adenyl cyclase which causes the formation of cAMP which causes relaxation of bronchial smooth muscle/inhibits action of acetylcholine at type 3 muscarinic receptors to cause bronchodilation
ADR: pharyngitis, tachycardia, nervousness, tremor/bronchitis, URTIs
Not renally or hepatically dosed
Tiotropium
Brand: Spiriva
Class: anticholinergic agent
Indication: COPD maintenance therapy
MOA: inhibits action of acetylcholine at type 3 muscarinic receptors to cause bronchodilation
ADR: bronchitis, URTIs
Not renally or hepatically dosed
Montelukast
Brand: Singulair
Class: leukotreine receptor antagonist
Indication: asthma (maintenance therapy), seasonal and allergic rhinitis
MOA: inhibits cysteinyl leukotreine receptor to reduce inflammation in the lungs and asthma symptoms
ADR: well tolerated, rare psychiatric disorders
Not renally or hepatically dosed
Levocetirizine
Brand: Xyzal
Class: 2nd generation antihistamine
Indication: allergic rhinitis, urticaria
MOA: selectively antagonizes peripheral histamine H1-receptors
ADR: drowsiness, fatigue, headache
Renally dosed
Loratadine
Brand: Claritin
Class: 2nd generation antihistamine
Indication: allergic rhinitis, urticaria
MOA: selectively antagonizes peripheral histamine H1-receptors
ADR: drowsiness, fatigue, headache
Renally dosed
Hydroxyzine
Brand: Atarax, Vistaril
Class: 1st generation antihistamine
Indication: anxiety, pruritis
MOA: antagonizes H1-receptors; has additional action at dopaminergic, muscarinic, and serotonergic (5HT2) receptors
ADR: drowsiness, dry mouth
Renally dosed
Allopurinol
Brand: Zyloprim
Class: xanthine oxidase inhibitor/antigout agent
Indication: gout (including prevention), nephrolithiasis prevention, tumor lysis syndrome prevention
MOA: inhibits xanthine oxidase which is the enzyme responsible for the conversion of hypoxanthine to uric acid
ADR: rash, gout attack, N/V/D
Renally dosed
Alendronate
Brand: Fosamax
Class: bisphosphonate derivative
Indication: osteoporosis (including prevention), Paget disease
MOA: adheres to sites of bone resorption to inhibit osteoclast activity; causes decrease in bone turnover
ADR: GI, musculoskeletal pain, rare irritation of upper GI mucosa and focal osteonecrosis
Renally dosed
Mesalamine
Brand: Canasa, Rowasa, Pentasa
Class: 5-aminosalicylic acid derivative
Indication: Crohn disease, ulcerative colitis
MOA: unknown but likely due to impact on chemical mediators of the inflammatory response at the area of application
ADR: abdominal pain, constipation, belching, headache
Not renally or hepatically dosed
Methotrexate
Brand: Trexall
Class: antineoplastic, antimetabolite (antifolate), antirheumatic, immunosuppressant agent
Indication: oncologic conditions, psoriasis, RA
MOA: inhibits dihydrofolate reductase to interfere with DNA synthesis, repair, and cellular replication
ADR: N/V, myelosuppression, alopecia, stomatitis, photosensitivity, rash, rare nephrotoxicity or hepatotoxicity, opportunistic infections, secondary malignancies
Renally and hepatically dosed
Hydroxychloroquine
Brand: Plaquenil
Class: aminoquinoline
Indication: malaria (including prevention), lupus erythematosus, RA
MOA: exact MOA unknown, potentially interferes with functions of select parasites
ADR: visual disturbances, blood dyscrasis, nausea
Not renally or hepatically dosed
Prednisone
Brand: Deltasone
Class: corticosteroid
Indication: anti-inflammatory and/or immunosuppressive agent used for a variety of conditions
MOA: decreases chemical mediators of inflammation by inducing phospholipase A2 (PLA2) inhibitory proteins and inhibiting arachidonic acid release resulting in anti-inflammatory, antipruritic, and vasoconstrictive effects
ADR: short-term: GI, mood changes, hyperglycemia, weight gain, HTN; long-term: osteoporosis, increased infection risk, adrenal suppression
Not renally or hepatically dosed
Prednisolone
Brand: Millipred, Orapred, Pediapred, Veripred
Class: corticosteroid
Indication: anti-inflammatory and/or immunosuppressive agent used for a variety of conditions
MOA: decreases chemical mediators of inflammation by inducing phospholipase A2 (PLA2) inhibitory proteins and inhibiting arachidonic acid release resulting in anti-inflammatory, antipruritic, and vasoconstrictive effects
ADR: short-term: GI, mood changes, hyperglycemia, weight gain, HTN; long-term: osteoporosis, increased infection risk, adrenal suppression
Not renally or hepatically dosed
Methylprednisolone
Brand: Medrol
Class: corticosteroid
Indication: anti-inflammatory and/or immunosuppressive agent used for a variety of conditions
MOA: decreases chemical mediators of inflammation by inducing phospholipase A2 (PLA2) inhibitory proteins and inhibiting arachidonic acid release resulting in anti-inflammatory, antipruritic, and vasoconstrictive effects
ADR: short-term: GI, mood changes, hyperglycemia, weight gain, HTN; long-term: osteoporosis, increased infection risk, adrenal suppression
Not renally or hepatically dosed
Sumatriptan
Brand: Imitrex
Class: serotonin 5-HT receptor agonist
Indication: migraines, cluster headaches
MOA: selective serotonin agonist that causes vasoconstriction that reduces neurogenic inflammation
ADR: tingling, lightheadedness, muscle weakness, dizziness, drowsiness
Hepatically dosed
Rizatriptan
Brand: Maxalt
Class: serotonin 5-HT receptor agonist
Indication: migraines
MOA: selective serotonin agonist that causes vasoconstriction that reduces neurogenic inflammation
ADR: tingling, lightheadedness, muscle weakness, dizziness, drowsiness
Not renally or epatically dosed
Testosterone
Brand: Androderm, Androgel, Fortesta, Testim
Class: androgen
Indication: delayed puberty, hypogonadism
MOA: principle androgen responsible for promoting growth of male sex organs; forms a hormone-receptor complex
ADR: increased PSA, emotional lability, HTN
Not renally or hepatically dosed
Progesterone
Brand: Prometrium
Class: progestin
Indication: abnormal uterine bleeding, endometrial hyperplasia (prevention)
MOA: steroid hormone that induces secretory changes in endometrium, relaxes uterine smooth muscle, blocks folliular maturation and ovulation, and maintains pregnancy
ADR: weight change, HA, amenorrhea, breast tenderness, abdominal pain, rare thromboembolic events, osteoporosis
Hepatically dosed
Estradiol (oral, topical, vaginal)
Brand: topical patches: Vivelle-Dot, Alora, Climara
tablets: Estrace; cream: Estrace
Divigel, Femring vaginal insert, Estring vaginal insert, Vagifem suppository
Class: estrogen derivative
Indication: Systemic: menopause symptoms (vasomotor, vaginal/vulvar atrophy); hypoestrogenism; breast cancer
Topical/Vaginal: menopause symptoms (vaginal/vulvar atrophy)
MOA: responsible for development and maintenance of female reproductive system; modulates pituitary secretion of gonadotropins, LH, and FSH
ADR: weight change, N/V, breast tenderness, mood change; rare- thromboembolic events, heart disease, breast/endometrial/ovarian cancer
Hepatically dosed
Ethinyl estradiol/norethindrone
Brand: Loestrin FE, Microgestin FE, Junel FE
Class: estrogen and progestin combination
Indication: acne, contraception, menopause symptoms (vasomotor)
MOA: inhibits ovulation via a negative feedback mechanism which alters gonadotropin secretion of FSH and LH; alters cervical mucus
ADR: nausea, headache, menstrual irregularities, breast tenderness; rare- thromboembolic events
Hepatically dosed
Ethinyl estradiol/norgestimate
Brand: Ortho-Cyclen, Sprintec, Tri-Cyclen, TriSprintec, Trinessa
Class: estrogen and progestin combination
Indication: acne, contraception
MOA: inhibits ovulation via a negative feedback mechanism which alters gonadotropin secretion of FSH and LH; alters cervical mucus
ADR: nausea, headache, menstrual irregularities, breast tenderness; rare- thromboembolic events
Hepatically dosed
Ethinyl estradioll/levonorgestrel
Brand: Alesse, Triphasil
Class: estrogen and progestin combination
Indication: contraception (including emergency contraception)
MOA: inhibits ovulation via a negative feedback mechanism which alters gonadotropin secretion of FSH and LH; alters cervical mucus
ADR: nausea, headache, menstrual irregularities, breast tenderness; rare- thromboembolic events
Hepatically dosed
Drospirenone/ethinyl estradiol
Brand: Yasmin, Zarah, Syeda, Ocella
Class: estrogen and progestin combination
Indication: acne, contraception, premenstural dysphoric disorder (PMDD)
MOA: inhibits ovulation via a negative feedback mechanism which alters gonadotropin secretion of FSH and LH; alters cervical mucus
ADR: nausea, headache, menstrual irregularities, breast tenderness; rare- thromboembolic events
Both renally and hepatically dosed
Desogestrel/ethinyl estradiol
Brand: Apri, Caziant, Ortho Cept
Class: estrogen and progestin combination
Indication: contraception
MOA: inhibits ovulation via a negative feedback mechanism which alters gonadotropin secretion of FSH and LH; alters cervical mucus
ADR: nausea, headache, menstrual irregularities, breast tenderness; rare- thromboembolic events
Hepatically dosed